Tega Industries Q1 FY27 Earnings Call Transcript Released
Tega Industries released its Q1 FY27 earnings call transcript. Consolidated revenue reached INR17.2 billion with 15% EBITDA margin. Legacy Tega revenue grew 21% to INR4.3 billion, with consumables up 36% to INR4 billion. Molycop contributed INR12.9 billion in revenue. Integration synergies of USD20 million are expected.
The announcement provides detailed financial performance and integration updates, including initial contributions from the acquired Molycop business and forward-looking statements on synergies and market outlook. This level of detail is material for investors.
The company reported strong year-on-year growth in revenue and EBITDA for its legacy businesses, alongside positive initial contributions from Molycop. Management expressed confidence in future growth and synergy realization.
Tega Industries Limited has released the transcript of its Earnings Conference Call for the Quarter ended June 30, 2026, held on August 13, 2026. The call featured management from Tega Industries and Molycop, discussing the company's performance and integration progress.
On a consolidated basis, the group reported revenue of INR17.2 billion and an adjusted EBITDA of INR2.6 billion, with an EBITDA margin of 15%. This included one-time expenses of INR1.9 billion related to acquisition and integration. The legacy Tega businesses showed robust performance with revenue increasing by 21% year-on-year to INR4.3 billion and EBITDA growing by 42% to INR1 billion, achieving an EBITDA margin of 22.1%. The consumables business within Tega saw revenue grow by 36% to INR4 billion and EBITDA increase by 58% to INR1 billion, with margins expanding to 24.1%. The equipment business experienced a softer quarter with revenue of INR358 million.
Molycop contributed INR12.9 billion in revenue and generated an EBITDA of INR1.6 billion with a 13% margin before one-time expenses. Integration efforts are progressing well, with expected synergies of approximately USD20 million over the next two to two and a half years, focusing on cost optimization and operational efficiencies. The company anticipates revenue ramp-up from cross-selling opportunities between Tega and Molycop from Q3 to Q4 of the fiscal year.
Market conditions for gold and copper remain strong, with projected CAGRs of 2.2% and 4.8% respectively. Tega Industries is well-positioned to benefit from these favorable industry fundamentals. The Chile plant commissioning is on track for soft commissioning around January 2027, with commercial production targeted for March 2027, subject to regulatory approvals. The company confirmed that all one-time expenses related to the Molycop acquisition have been factored into the Q1 results.
What to do with a filing like this
Tega Industries Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tega Industries Limited. Read the original for the full detail.